Cures for HIV and blurred vision and using cosmic rays to monitor nuclear waste drums are on our list of recent promising university spinouts.

The cancer drug developer popped after an upsized offering, allowing Alexandria Venture Investments to exit and showing the IPO market is still breathing in the US.

The UK health insurer says it is a good time to launch a fund as the froth has come out of valuations and "sensible" money can go in.

NCSoft invested $15m in Mysten Labs to take the latter’s series B round to $300m while Porsche backed Xanadu’s $100m series C.

Suzano and Yara participated in Agrolend’s $145m latest round while Xencor contributed to Zenas BioPharma’s $118m series B.

Xiaomi provided $68.9m in series C funding for Atech Automotive while Intel and Micron were part of Eliyan’s $40m series A round.

Cable One provided $50m for Ziply Fiber while Mercuria co-led a series C round the same size for The Mobility House.

Paragon Biosciences was part of Emalex Biosciences’ $250m series D while CMA CGM and AP Moller participated in an $80m round for Project44.

Databricks, Dell, HPE and Salesforce were all part of Alation’s $123m series E round while Alphabet took part in AMP Robotics’ $91m series C.

Sumitomo Corporation of Americas took part in ColdQuanta’s $100m series B round while Tesi provided $31.6m in series B funding for VoltAero.